Literature DB >> 16399952

Adenosine regulation of cystic fibrosis transmembrane conductance regulator through prostenoids in airway epithelia.

Yao Li1, Wei Wang, William Parker, J P Clancy.   

Abstract

Cystic fibrosis is caused by dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, leading to altered ion transport, chronic infection, and excessive inflammation. Here we investigated regulation of CFTR in airway cell monolayers by adenosine, adenosine receptors, and arachidonic acid. Our studies demonstrate that the A2B adenosine receptor is expressed at high levels relative to the other adenosine receptor subtypes, with a characteristic low-affinity profile for adenosine-stimulated CFTR Cl- currents in both Calu-3 cells and CFBE41o- airway cell monolayers stably transduced with wild-type CFTR. The levels of adenosine found in sputum from patients with cystic fibrosis with moderate to severe lung disease stimulated apical prostaglandin release in Calu-3 and CFBE41o- cells, implicating adenosine regulation of phospholipase A2 (PLA2) activity. A2B adenosine receptor and arachidonic acid stimulation produced CFTR-dependent currents in airway monolayers and increased cAMP levels that were sensitive to cyclooxygenase inhibition. Arachidonic acid demonstrated dual regulation of CFTR, stimulating CFTR and Cl- currents in intact airway monolayers, and potently inhibiting PKA-activated Cl- currents in excised membrane patches. Cl- currents produced by arachidonic acid were sensitive to inhibition of PKA, cyclooxygenase, and 5-lipoxygenase. Together, the results provide a converging mechanism to link regulation of CFTR and airway cell inflammation through adenosine and adenosine receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16399952      PMCID: PMC2644223          DOI: 10.1165/rcmb.2005-0421OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  44 in total

Review 1.  Adenosine receptors.

Authors:  M E Olah; G L Stiles
Journal:  Annu Rev Physiol       Date:  1992       Impact factor: 19.318

2.  Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis.

Authors:  J P Clancy; Z Bebök; F Ruiz; C King; J Jones; L Walker; H Greer; J Hong; L Wing; M Macaluso; R Lyrene; E J Sorscher; D M Bedwell
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

3.  Direct modulation of secretory chloride channels by arachidonic and other cis unsaturated fatty acids.

Authors:  T C Hwang; S E Guggino; W B Guggino
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 4.  Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses.

Authors:  Yoshihide Kanaoka; Joshua A Boyce
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

5.  Effect of high-dose ibuprofen in patients with cystic fibrosis.

Authors:  M W Konstan; P J Byard; C L Hoppel; P B Davis
Journal:  N Engl J Med       Date:  1995-03-30       Impact factor: 91.245

6.  Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.

Authors:  M W Konstan; K A Hilliard; T M Norvell; M Berger
Journal:  Am J Respir Crit Care Med       Date:  1994-08       Impact factor: 21.405

Review 7.  Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation.

Authors:  Aaron N Hata; Richard M Breyer
Journal:  Pharmacol Ther       Date:  2004-08       Impact factor: 12.310

8.  Nucleotide release provides a mechanism for airway surface liquid homeostasis.

Authors:  Eduardo R Lazarowski; Robert Tarran; Barbara R Grubb; Catharina A van Heusden; Seiko Okada; Richard C Boucher
Journal:  J Biol Chem       Date:  2004-06-21       Impact factor: 5.157

9.  Activation of airway cl- secretion in human subjects by adenosine.

Authors:  Karen Hentchel-Franks; David Lozano; Valerie Eubanks-Tarn; Bryan Cobb; Lijuan Fan; Robert Oster; Eric Sorscher; J P Clancy
Journal:  Am J Respir Cell Mol Biol       Date:  2004-03-23       Impact factor: 6.914

10.  Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway.

Authors:  Christopher L Karp; Leah M Flick; Kiwon W Park; Samir Softic; Todd M Greer; Raquel Keledjian; Rong Yang; Jasim Uddin; William B Guggino; Sowsan F Atabani; Yasmine Belkaid; Yan Xu; Jeffrey A Whitsett; Frank J Accurso; Marsha Wills-Karp; Nicos A Petasis
Journal:  Nat Immunol       Date:  2004-03-21       Impact factor: 25.606

View more
  21 in total

Review 1.  Adenosine signaling and the regulation of chronic lung disease.

Authors:  Yang Zhou; Daniel J Schneider; Michael R Blackburn
Journal:  Pharmacol Ther       Date:  2009-05-05       Impact factor: 12.310

2.  Sustained adenosine exposure causes lung endothelial barrier dysfunction via nucleoside transporter-mediated signaling.

Authors:  Qing Lu; Julie Newton; Vivian Hsiao; Paul Shamirian; Michael R Blackburn; Mesias Pedroza
Journal:  Am J Respir Cell Mol Biol       Date:  2012-06-28       Impact factor: 6.914

Review 3.  Ion channels in inflammation.

Authors:  Michael Eisenhut; Helen Wallace
Journal:  Pflugers Arch       Date:  2011-01-29       Impact factor: 3.657

4.  Accelerating Post-SELEX Aptamer Engineering Using Exonuclease Digestion.

Authors:  Juan Canoura; Haixiang Yu; Obtin Alkhamis; Daniel Roncancio; Rifat Farhana; Yi Xiao
Journal:  J Am Chem Soc       Date:  2020-12-30       Impact factor: 15.419

5.  New insights into the regulation of inflammation by adenosine.

Authors:  Joel Linden
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

6.  Transcellular passage of Neisseria meningitidis across a polarized respiratory epithelium.

Authors:  Thomas C Sutherland; Paola Quattroni; Rachel M Exley; Christoph M Tang
Journal:  Infect Immun       Date:  2010-06-28       Impact factor: 3.441

7.  A stabilizing influence: CAL PDZ inhibition extends the half-life of ΔF508-CFTR.

Authors:  Patrick R Cushing; Lars Vouilleme; Maria Pellegrini; Prisca Boisguerin; Dean R Madden
Journal:  Angew Chem Int Ed Engl       Date:  2010-12-17       Impact factor: 15.336

8.  Alterations in adenosine metabolism and signaling in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.

Authors:  Yang Zhou; Jayasimha N Murthy; Dewan Zeng; Luiz Belardinelli; Michael R Blackburn
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

Review 9.  Adenosine signaling during acute and chronic disease states.

Authors:  Harry Karmouty-Quintana; Yang Xia; Michael R Blackburn
Journal:  J Mol Med (Berl)       Date:  2013-01-23       Impact factor: 4.599

10.  Prostaglandin E₂regulation of cystic fibrosis transmembrane conductance regulator activity and airway surface liquid volume requires gap junctional communication.

Authors:  K E Ludwig Scheckenbach; Davide Losa; Tecla Dudez; Marc Bacchetta; Scott O'Grady; Sophie Crespin; Marc Chanson
Journal:  Am J Respir Cell Mol Biol       Date:  2010-02-18       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.